Immune responses in mice to arecoline mediated by lymphocyte muscarinic acetylcholine receptor

Cell Biology International

Volumn 30, Issue 12, 2006, Pages 1048-1053

  Wen, Xiao ming ^a,b   Zhang, Ying li ^b   Liu, Xin min ^a   Guo, Shun xing ^a   Wang, Hai ^b  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

Arecoline; Hemolysin; Interleukin 2; Lymphocyte; Muscarinic receptor; Proliferation

Indexed keywords

ARECOLINE; ATROPINE; HEMOLYSIN; INTERLEUKIN 2; LYMPHOCYTE RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN BLOOD LEVEL; SHEEP ERYTHROCYTE; SPLEEN; SPLEEN CELL; STATISTICAL SIGNIFICANCE;

ANIMALS; ARECOLINE; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; RECEPTORS, MUSCARINIC; SPLEEN; T-LYMPHOCYTES;

ANIMALIA; OVIS ARIES;

EID: 33750981001     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2006.09.015     Document Type: Article

References (35)

1. Adhvaryu S.G., Dave B.J., and Trivedi A.H. Cytogenetic surveillance of tobacco-areca nut (mava) chewers. Mutat Res 261 (1991) 41-49
2. Asthana S., Raffaele K.C., Greig N.H., Berardi A., Morris P.P., Schapiro M.B., et al. Neuroendocrine responses to intravenous infusion of arecoline in patients with Alzheimer's disease. Psychoneuroendocrinology 20 6 (1995) 623-636
3. Asthana S., Greig N.H., Holloway H.W., Raffaele K.C., Berardi A., Schapiro M.B., et al. Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease. Clin Pharmacol Ther 60 3 (1996) 276-282
4. Avery E.E., Baker L.D., and Asthana S. Potential role of muscarinic agonists in Alzheimer's disease. Drugs Aging 11 6 (1997) 450-459
5. Chatterjee A., and Deb S. Genotoxic effects of arecoline either by the peritoneal or oral route in murine bone marrow cells and the influence of N-acetylcysteine. Cancer Lett 139 (1999) 23-31
6. Davis K.L., and Mohs R.C. Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine. Am J Psychiatry 9 (1982) 1421-1424
7. Demissie S., Rogers C.F., Hiramoto N.S., Ghanta V.K., and Hiramoto R.N. Arecoline a muscarinic cholinergic agent conditions central pathways that modulate natural killer cell activity. J Neuroimmunol 59 1-2 (1995) 57-63
8. Denizot F., and Lang R. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89 (1986) 271
9. Fujino H., Kitamura Y., Yada T., Uehara T., and Nomura Y. Stimulatory roles of muscarinic acetylcholine receptors on T cell antigen receptor/CD3 complex-mediated interleukin-2 production in human peripheral blood lymphocytes. Mol Pharmacol 51 (1997) 1007-1014
10. Haxby J.V. Memory improvement without toxicity during chronic low dose intravenous arecoline in Alzheimer's disease. Psychopharmacology 112 (1993) 421-427
11. Jeng J.H., Wang Y.J., Chiang B.L., Lee P.H., Chan C.P., Ho Y.S., et al. Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-a production of oral epithelial cells by areca nut extract and arecoline. Carcinogenesis 24 8 (2003) 1301-1315
12. Jun N., Toru H., Yasunnobu O., and Yasuyuki N. The presence and functions of muscarinic receptors in human T cells: The involvement in IL-2 and IL-2 receptor system. Life Sci 72 (2003) 2121-2126
13. Kawashima K., and Fujii T. Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther 86 (2000) 29-48
14. Kihara T., and Shimohama S. Alzheimer's disease and acetylcholine receptors. Acta Neurobiol Exp (Wars) 64 1 (2004) 99-105
15. Messer W.S., Ellerbrock B., Price M., and Hoss W. Autoradiographic analyses of agonist binding to muscarinic receptor subtypes. Biochem Pharmacol 138 (1989) 837-850
16. Novak T.J., and Rothenberg E.V. cAMP inhibits induction of interleukin-2 but not of interleukin-4 in T cells. Proc Natl Acad Sci USA 87 (1990) 9353-9357
17. Okuma Y., and Nomura Y. Roles of muscarinic acetylcholine receptors in interleukin-2 synthesis in lymphocytes. Jpn J Pharmacol 85 (2001) 16-19
18. Panigrahi G.B., and Rao A.R. Study of the genotoxicity of the total aqueous extract of betel nut and its tannins. Carcinogenesis 7 (1996) 37-39
19. Prync A.E., Arzt E., Fernandez C.S., Finkielman S., and Nahmod V. The inhibitory effect of the muscarinic agonist pilocarpine on lymphocyte activation involves the IL-2 pathway and the increase in suppressor cell function. Int J Neurosci 62 3-4 (1992) 277-285
20. Rabey J.M., Shaenkman L., and Gilad G.M. Cholinergic muscarinic binding by human lymphocytes: changes with aging, antagonist treatment, and senile dementia of the Alzheimer type. Ann Neurol 20 (1986) 628-631
21. Raffaele K.C., Berardi A., Asthana S., Morris P., Haxby J.V., and Soncrant I.T. Effects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type. Psychopharmacol Bull 27 (1991) 315-319
22. Rinner I., Globerson A., Kawashima K., Korsatko W., and Schauenstein K. A possible role for acetylcholine in the dialogue between thymocytes and thymic stroma. Neuroimmunodulation 6 1-2 (1999) 51-55
23. Selvan R.S., and Rao A.R. Influence of arecoline on immune system: III. Suppression of B cell-mediated immune response in mice after short-term exposure. Immunopharmacol Immunotoxicol 15 2-3 (1993) 291-305
24. Selvan R.S., Venkateswaran K.S., and Rao A.R. Influence of arecoline on immune system: I. Short term effects on general parameters and on the adrenal and lymphoid organs. Immunopharmacol Immunotoxicol 11 2-3 (1989) 347-377
25. Selvan R.S., Selvakumaran M., and Rao A.R. Influence of arecoline on immune system: II. Suppression of thymus-dependent immune responses and parameter of non-specific resistance after short-term exposure. Immunopharmacol Immunotoxicol 13 3 (1991) 281-309
26. Shahabuddin S., and Rao A.R. Effect of arecoline on the humoral and cell mediated immune response in mice. Indian J Exp Biol 18 (1980) 1493
27. Sharan R.N. Association of betel nut with carcinogenesis. Cancer J 9 (1996) 13-19
28. Silkworth J.B., and Loose L.D. Assessment of environmental contaminant-induced lymphocyte dysfunction. Environ Health Perspect 39 (1981) 105
29. Soncrant I.T., Raffaele K.C., Asthana S., Berardi A., Morris P.P., and Haxby J.V. Memory improvement without toxicity during chronic low dose intravenous arecoline in Alzheimer's disease. Psychopharmacology 112 (1993) 421-427
30. Strom T.B., Lane M.A., and George K. The parallel, time-dependent, bimodal change in lymphocyte cholinergic binding activity and cholinergic influence upon lymphocyte-mediated cytotoxicity after lymphocyte activation. J Immunol 127 (1981) 705-710
31. Tamir A., and Isakov N. Cyclic AMP inhibits phosphatidylinositol-coupled and -uncoupled mitogenic signals in T lymphocytes. J Immunol 152 (1994) 3391-3399
32. Tsuruta J., Lee H.J., Masuda E.S., Nakagawa N.K., Arai N., and Aai K. Tyokota. Cyclic AMP inhibits expression of IL-2 gene through the nuclear factors of activated T cells site, and transfection of NF-AT cDNAs abrogates the sensitivity of EL-4 cells to cyclic AMP. J Immunol 154 (1995) 5255-5264
33. Volger B.W. Alternatives in the treatment of memory loss in patients with Alzheimer's disease. Clin Pharm 10 6 (1991) 447-456
34. Wessler I., Kirkpatrick C.J., and Racke K. The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol 26 (1999) 198-205
35. Zheng X.J., Qin X.M., and Zheng X.L. Study on the effects of arecoline on myoelectric activity of uterine smooth muscle of unpregnancy and early pregnancy rats and its action mechanism. Chin J Pract Chin Mod Med 18 1 (2005) 151-153 (in Chinese)